Annotation Detail

Information
Associated Genes
HRAS
Associated Variants
HRAS MUTATION
HRAS MUTATION
Associated Disease
Rhabdoid Tumor of the Kidney
Source Database
DisGeNET
Description
Using mutant HRAS (HRAS*) as an oncogenic prototype, we obtained evidence in transgenic mice that RTK/RAS pathway activation in urothelial cells causes hyperplasia that neither progresses to frank carcinoma nor regresses to normal urothelium through a period of one year.
Pubmed
25795707
Section of the abstract supporting the evidence
ALL_TEXT_1/3
Number of the section of the abstract supporting the evidence
1
Number of the sentence supporting the evidence
2
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.000271441872080303
Drugs